Corline Biomedical AB (CLBIO.ST)
SEK 8.76
(5.29%)
SEK 8.76
(5.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 886 Thousand | -6.45 Million | -4.83 Million | -5.06 Million | -13.83 Million | -4.1 Million |
| Net Income | -1.78 Million | 2.32 Million | -6.9 Million | -7.28 Million | -9.54 Million | -6.79 Million |
| Depreciation & Amortization | 97 Thousand | 56 Thousand | 31 Thousand | 14 Thousand | 9000.00 | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.59 Million | -8.83 Million | 2.05 Million | 2.2 Million | -4.3 Million | 2.68 Million |
| Other non-cash items | -21 Thousand | 4.33 Million | -13 Thousand | -984 Thousand | 1.74 Million | -1000.00 |
| Investing Cash Flow | -10.62 Million | -8.99 Million | -9.56 Million | -8.8 Million | -4.84 Million | -937 Thousand |
| Investments in PPE | -10.62 Million | -8.99 Million | -9.61 Million | -8.8 Million | -4.84 Million | -937 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 56 Thousand | - | - | - |
| Other Investing Activities | -10.48 Million | -8.84 Million | -9.42 Million | -8.75 Million | -4.84 Million | -891 Thousand |
| Financing Cash Flow | 537 Thousand | 26 Thousand | 47.12 Million | - | 13.89 Million | 15.82 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 537 Thousand | 26 Thousand | 50.63 Million | - | 13.95 Million | 15.82 Million |
| Other Financing Activities | 537 Thousand | 26 Thousand | -3.5 Million | - | -54 Thousand | 15.82 Million |
| Accounts receivables | 3 Million | -6.6 Million | -1.13 Million | 389 Thousand | -788 Thousand | 238 Thousand |
| Accounts payables | -2.37 Million | 2.38 Million | 518 Thousand | 623 Thousand | -943 Thousand | -1.47 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -405 Thousand | -4.61 Million | 2.66 Million | 1.19 Million | -2.57 Million | 3.92 Million |
| Cash at beginning of period | 26.21 Million | 41.63 Million | 8.9 Million | 22.85 Million | 27.64 Million | 16.85 Million |
| Cash at end of period | 17.01 Million | 26.21 Million | 41.63 Million | 8.99 Million | 22.85 Million | 27.64 Million |
| Capital Expenditure | -10.62 Million | -8.99 Million | -9.61 Million | -8.8 Million | -4.84 Million | -937 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -9.19 Million | -15.42 Million | 32.73 Million | -13.86 Million | -4.78 Million | 10.78 Million |
| Free Cash Flow | -9.73 Million | -15.45 Million | -14.45 Million | -13.86 Million | -18.68 Million | -5.04 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.36 Million | -1.66 Million | -600 Thousand | -1.8 Million | 204 Thousand | -2.4 Million |
| Depreciation & Amortization | 23 Thousand | 22 Thousand | 24 Thousand | 97 Thousand | 25 Thousand | 25 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.66 Million | 3.94 Million | 3 Million | 2.59 Million | -1.8 Million | 5.83 Million |
| Other non-cash items | -1.71 Million | -2.1 Million | -2.77 Million | -439 Thousand | -25 Thousand | -1000.00 |
| Investing Cash Flow | -4.25 Million | -1.83 Million | -2.41 Million | -10.62 Million | -2.7 Million | -2.52 Million |
| Investments in PPE | -4.25 Million | -1.83 Million | -2.41 Million | -10.62 Million | -2.7 Million | -2.52 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -4.25 Million | -1.83 Million | -2.41 Million | -10.48 Million | -2.7 Million | -2.49 Million |
| Financing Cash Flow | 224 Thousand | - | - | 537 Thousand | - | 537 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 224 Thousand | - | - | 537 Thousand | - | 537 Thousand |
| Other Financing Activities | 224 Thousand | - | - | 537 Thousand | - | 537 Thousand |
| Accounts receivables | -370 Thousand | 1.19 Million | 1.65 Million | 3 Million | 894 Thousand | 5.53 Million |
| Accounts payables | 2.12 Million | 955 Thousand | 1.16 Million | -2.37 Million | -2.17 Million | -1.4 Million |
| Inventory | - | - | - | - | 2000.00 | - |
| Other working capital | 1.9 Million | 1.79 Million | 185 Thousand | 1.96 Million | -520 Thousand | 1.7 Million |
| Cash at beginning of period | 17.47 Million | 17.01 Million | 17 Million | 26.21 Million | 21.29 Million | 19.84 Million |
| Cash at end of period | 12.76 Million | 17.47 Million | 17.01 Million | 17.01 Million | 17 Million | 21.29 Million |
| Capital Expenditure | -4.25 Million | -1.83 Million | -2.41 Million | -10.62 Million | -2.7 Million | -2.52 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -4.71 Million | 461 Thousand | 12 Thousand | -9.19 Million | -4.29 Million | 1.45 Million |
| Free Cash Flow | -4.93 Million | 461 Thousand | 12 Thousand | -9.73 Million | -4.29 Million | 921 Thousand |
6718
ULH
KAR
TLIK
SAMS
1885